(Q37873600)

24 August 2017

title

Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae (English)

1 reference

24 August 2017

0 references

Chlamydia pneumoniae

1 reference

Black PN

1

1 reference

24 August 2017

Blasi F

2

1 reference

24 August 2017

Jenkins CR

3

1 reference

24 August 2017

Scicchitano R

4

1 reference

24 August 2017

Mills GD

5

1 reference

24 August 2017

Rubinfeld AR

6

1 reference

24 August 2017

Ruffin RE

7

1 reference

24 August 2017

Mullins PR

8

1 reference

24 August 2017

Dangain J

9

1 reference

24 August 2017

Cooper BC

10

1 reference

24 August 2017

David DB

11

1 reference

24 August 2017

Allegra L

12

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

164

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

536-541

1 reference

A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Chlamydia pneumoniae serological status is not associated with asthma in children or young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Chlamydia pneumoniae and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Chronic Chlamydia pneumoniae infection and asthma exacerbations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

The association of Chlamydia pneumoniae infection and reactive airway disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

Persistent infection with Chlamydia pneumoniae following acute respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

In vitro studies of Chlamydia trachomatis susceptibility and resistance to rifampin and rifabutin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2011040

10.1164/AJRCCM.164.4.2011040

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference